Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Affordable Care Act
    • Consumer-Driven Health Care
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Drug Prices & Regulations
    • Health Economics & Costs
    • Health Insurance
    • Health Reform
    • Medical Tourism
    • Medicare
    • Single-Payer/Medicare-for-All
    • Telemedicine
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Category: Cost of Healthcare

Finally: FDA to Allow OTC Hearing Aids without a Prescription

Posted on August 17, 2022August 16, 2022 by Devon Herrick

On Tuesday the U.S. Food and Drug Administration (FDA) finally cleared the way for over-the-counter (OTC) hearing aids. Yes, this is a “no-brainer”, and the most obvious question is: why did it take so long? The law allowing the FDA to approve OTC hearing aids was passed in five years ago, in August 2017.

Under the new rule, people with mild to moderate hearing loss should be able to buy hearing aids online and in retail stores as soon as October, without being required to see a doctor for an exam to get a prescription.

+

Tuesday Links – 16 August 2022

Posted on August 16, 2022August 15, 2022 by John C. Goodman
  • Public-health communication around monkeypox has been an orgy of euphemism and wokespeak, misleading and baffling if you don’t understand what isn’t being said.
  • Kids going crazy: “Between 2016 and 2020, there were significant increases in children’s diagnosed anxiety and depression.” 
  • Financial therapy integrates financial and emotional wellness. But is it health care?
  • Birx:  pharmaceutical giants Pfizer and Moderna are to blame for thousands of deaths because their refusal to pursue a “compassionate use authorization” for the COVID-19 vaccines led to a delay which directly impacted nursing home residents.
+

During a Nursing Shortage Nurses Abandon Hospitals

Posted on August 12, 2022August 11, 2022 by Devon Herrick

Physicians have long dabbled in cosmetic medicine to boost their incomes. It is interesting to note that their cosmetic practices are competitive with transparent pricing, while their therapeutic areas of practice is bureaucratic with opaque prices. As a result of competition, cosmetic surgery prices have risen about equal to consumer inflation, which is one-third the rate of medical inflation.

+

Who Benefits from Drug Rebates? Mostly Health Plans (Not Consumers)

Posted on August 10, 2022August 11, 2022 by Devon Herrick

Pharmacy Benefit Managers (PBMs) have been in the news lately. PBMs manage drug benefits for insurers, self-insured employer health plans, Medicare Advantage plans and Medicare Part D. Recently executives from the three largest PBMs were hauled before Congress to discuss their business models. One reason for scrutiny is that the three largest PBMs control about 80% of the market.

+
  • Previous
  • 1
  • …
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • …
  • 95
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 13 other subscribers

Popular Topics

©2023 The Goodman Institute Health Blog | Website by Lexicom